The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.

IF 12.9 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Jennifer C Lai, Amy M Shui, Michele Molinari, Robert Rahimi, Daniela Ladner, Daniel Ganger, Matthew Kappus, Elizabeth King, Amit Tevar, Michael Volk, Andres Duarte-Rojo, Elizabeth C Verna
{"title":"The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.","authors":"Jennifer C Lai, Amy M Shui, Michele Molinari, Robert Rahimi, Daniela Ladner, Daniel Ganger, Matthew Kappus, Elizabeth King, Amit Tevar, Michael Volk, Andres Duarte-Rojo, Elizabeth C Verna","doi":"10.1097/HEP.0000000000001320","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Frailty is strongly associated with mortality after liver transplantation. However, national guidelines discourage its use as a sole reason to decline a patient for liver transplantation, as some frail patients have acceptable outcomes. We aimed to develop a composite index, the Liver Transplant Comorbidity Index (LTCI), integrating frailty and other comorbidities, as a risk factor for longer-term (3-year) post-transplant mortality.</p><p><strong>Methods: </strong>This 8-center prospective Functional Assessment in Liver Transplantation (FrAILT) Study included adult recipients of a primary deceased donor liver transplant from 2012-2022. Frailty was measured using the Liver Frailty Index (LFI ≥4.5=frail). Other candidate variables included demographics, laboratories, and comorbidities. Cox proportional hazards regression with best subset selection was used to identify risk factors of 3-year post-transplant death. The final model was selected based on Aikaike Information Criterion and clinical pragmatism.</p><p><strong>Results: </strong>Of 1,472 liver transplant recipients. 290 (20%) were frail. Three-year post-transplant mortality was higher in frail versus non-frail patients (13 vs. 8%; p=0.03). The final LTCI included 5 variables: frailty, coronary artery disease, hepatocellular carcinoma, renal dysfunction, and diabetes. Three-year post-transplant mortality in low-, moderate-, and high-risk LTCI groups was 93%, 87%, and 80% respectively. In multivariable analysis, after adjusting for donor factors (age, DCD), both moderate- (HR 2.23; 95% CI 1.46-3.40; p<0.001) and high-risk (HR 2.78; 95% CI 1.67-4.64; p<0.001) status were associated with 3-year post-transplant mortality.</p><p><strong>Conclusion: </strong>The LTCI, comprising 5 pre-transplant clinical parameters, effectively identifies patients at increased risk of post-transplant mortality. By integrating frailty in the context of other co-morbidities, the LTCI can help providers better weigh the relative transplant risks and benefits and standardize selection of transplant candidates.</p>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":" ","pages":""},"PeriodicalIF":12.9000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HEP.0000000000001320","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Frailty is strongly associated with mortality after liver transplantation. However, national guidelines discourage its use as a sole reason to decline a patient for liver transplantation, as some frail patients have acceptable outcomes. We aimed to develop a composite index, the Liver Transplant Comorbidity Index (LTCI), integrating frailty and other comorbidities, as a risk factor for longer-term (3-year) post-transplant mortality.

Methods: This 8-center prospective Functional Assessment in Liver Transplantation (FrAILT) Study included adult recipients of a primary deceased donor liver transplant from 2012-2022. Frailty was measured using the Liver Frailty Index (LFI ≥4.5=frail). Other candidate variables included demographics, laboratories, and comorbidities. Cox proportional hazards regression with best subset selection was used to identify risk factors of 3-year post-transplant death. The final model was selected based on Aikaike Information Criterion and clinical pragmatism.

Results: Of 1,472 liver transplant recipients. 290 (20%) were frail. Three-year post-transplant mortality was higher in frail versus non-frail patients (13 vs. 8%; p=0.03). The final LTCI included 5 variables: frailty, coronary artery disease, hepatocellular carcinoma, renal dysfunction, and diabetes. Three-year post-transplant mortality in low-, moderate-, and high-risk LTCI groups was 93%, 87%, and 80% respectively. In multivariable analysis, after adjusting for donor factors (age, DCD), both moderate- (HR 2.23; 95% CI 1.46-3.40; p<0.001) and high-risk (HR 2.78; 95% CI 1.67-4.64; p<0.001) status were associated with 3-year post-transplant mortality.

Conclusion: The LTCI, comprising 5 pre-transplant clinical parameters, effectively identifies patients at increased risk of post-transplant mortality. By integrating frailty in the context of other co-morbidities, the LTCI can help providers better weigh the relative transplant risks and benefits and standardize selection of transplant candidates.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信